Conflicting interests: when whistleblowers profit from allegations of scientific misconduct

Recent  articles in Science and the New York Times focused primarily on the very serious topic of potential scientific misconduct. However, these articles only lightly touched upon the concept of short selling stock, and I believe this matter deserves more attention for its inherent conflicts of interest. Short selling entails borrowing shares of a stock, selling shares high, followed by buying shares back at a lower price and pocketing the difference. Short sellers profit from devaluing a stock. It is legal to devalue stocks using public statements, and short sellers will often use social media as a primary venue to make defamatory statements, expressed as opinions. This process is known as “short and distort.” 


https://www.jci.org/articles/view/166176












Comments

Popular posts from this blog

Interview of Elisabeth Bik – Scientific Editorial Director at uBiome

The troll Leonid Schneider & ‘For Better Science’: crank or cure?